Recent News from (OTC: BALOF)
|10%+ Yield Dividend Dogs Paced By Uniti Group's October Gains|
|Actionable Conclusions (1-10): Broker Analysts Predicted 20.4% To 76.1% Net Gains For Ten 10%+ DiviDogs By October 2018 Three of the ten top 10%+ DiviDogs by yield were verified as being among the top ten of thirty gainers for the coming year based on analyst 1-year target prices. (The...|
|Date: October, 08 2017 03:27|
About Clere AG (OTC: BALOF)
Balda is a provider of first class solutions for demanding, high quality applications lt br / gt in the fields of medical technology, optics, the automotive industry and other specialist industrial sectors. The company provides superior engineering services, products of the highest quality as well as a fast, flexible and tailored service for its customers at a competitive price. The Group s Balda Medical and Balda Technical divisions have operations worldwide, and the company maintains production facilities in Germany, the USA and Malaysia. The company s success is based on the deployment of leading edge, cost effective technologies, coupled with the trust based collaboration with customers.
- Dieter Brenken / CFO
- Clas Rohl / Head of IR
Current Share Structure
Daily Technical Chart for (OTC: BALOF)
Stay tuned for daily updates and more on (OTC: BALOF)
More to come on (OTC: BALOF)
Do your DD and if you choose, be ready to go!
The Research: All source information contained in this email is from the public sources mentioned below.
Disclaimer: OTC Report publishes reports providing information on selected companies. OTC Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. OTC Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in BALOF is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. OTC Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. OTC Report does not own any shares of BALOF and does not buy, sell, or trade any shares of BALOF. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by OTC Report. All rights reserved. Our Full Disclaimer: http://otc.report/disclaimer/